The majority of studies proposed in Projects 1-5 of this Conte center application will focus on the cell-type specific analysis of neuronal cell populations implicated in the pathophysiology of schizophrenia and their response to treatment with antipsychotic drugs. These studies will examine cellular processes ranging from mRNA transcription and translation, chromatin modification, protein phosphorylation, dendritic morphology, to whole cellular physiology and animal behavior. Virtually all of these investigations will make use of genetically modified mice, and thus the Animal Core will be devoted to facilitating these experiments. The existence of a centralized facility staffed with experienced personnel will ensure that all the mice needed for the proposed studies are available when needed, in a cost-effective manner.
Aim 1 of the Core will be the production of new Bacterial Artificial Chromosome (BAC) transgenic mouse lines.
In Aim 2, the testing of these transgenic animals will be characterized so as to validate them for use in the proposed studies. Finally, Aim 3 of the Core will be the breeding and maintenance of these and other existing mouse lines that will be used throughout the studies carried out in Projects 1-5.

Public Health Relevance

to public health: Schizophrenia is a debilitating psychiatric disorder affecting ~1 % of the population. New therapeutic treatments for schizophrenia are needed. The Animal Core will provide the care and breeding of the animal models necessary for work of this Conte Center Grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH090963-03
Application #
8382719
Study Section
Special Emphasis Panel (ZMH1-ERB-M)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
3
Fiscal Year
2012
Total Cost
$329,029
Indirect Cost
$61,640
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Milosevic, Ana; Liebmann, Thomas; Knudsen, Margarete et al. (2016) Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol :
Xu, Jian; Kurup, Pradeep; Azkona, Garikoitz et al. (2016) Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels. J Neurochem 136:285-94
Rapanelli, Maximiliano; Frick, Luciana R; Horn, Kyla D et al. (2016) The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons. J Biol Chem 291:21042-21052
Uematsu, Ken; Heiman, Myriam; Zelenina, Marina et al. (2015) Protein kinase A directly phosphorylates metabotropic glutamate receptor 5 to modulate its function. J Neurochem 132:677-86
Wang, Hong; Warner-Schmidt, Jennifer; Varela, Santiago et al. (2015) Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice. Proc Natl Acad Sci U S A 112:9745-50
Snyder, Gretchen L; Vanover, Kimberly E; Zhu, Hongwen et al. (2015) Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 232:605-21
Plattner, Florian; Hayashi, Kanehiro; Hernández, Adan et al. (2015) The role of ventral striatal cAMP signaling in stress-induced behaviors. Nat Neurosci 18:1094-100
Nakajima, Miho; Görlich, Andreas; Heintz, Nathaniel (2014) Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons. Cell 159:295-305
Dietz, David M; Kennedy, Pamela J; Sun, Haosheng et al. (2014) ýýFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes. Neuropsychopharmacology 39:538-44
Meyer, Douglas A; Torres-Altoro, Melissa I; Tan, Zhenjun et al. (2014) Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci 34:8259-67

Showing the most recent 10 out of 37 publications